Motto International Corp recalls Rhino 7 Platinum 30000 Capsules, in blue,orange,black background with red,white,blue,gray text in hologram paper packag…

Recall date

December 17, 2019

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0656-2020

FDA classification

Class I

Brand / firm

Motto International Corp

Sold / distributed

TX

Why it was recalled

Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil

Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.

What was recalled

Rhino 7 Platinum 30000 Capsules, in blue,orange,black background with red,white,blue,gray text in hologram paper packaging, packaged in 2, 4, and 10 count blister cards, Motto International, Dallas, TX